Scholar Rock Holding (SRRK) Return on Capital Employed (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 923.00 |
| Dec 31, 2025 | 626.00 |
| Sep 30, 2025 | -1,536.00 |
| Jun 30, 2025 | -3,292.00 |
| Mar 31, 2025 | 2,292.00 |
| Dec 31, 2024 | 5,102.00 |
| Sep 30, 2024 | -4,310.00 |
| Jun 30, 2024 | -2,273.00 |
| Mar 31, 2024 | -615.00 |
| Dec 31, 2023 | -113.00 |
| Sep 30, 2023 | -843.00 |
| Jun 30, 2023 | -534.00 |
| Mar 31, 2023 | -1,436.00 |
| Dec 31, 2022 | -515.00 |
| Sep 30, 2022 | 556.00 |
| Jun 30, 2022 | 335.00 |
| Mar 31, 2022 | 1,125.00 |
| Dec 31, 2021 | -665.00 |
| Sep 30, 2021 | -976.00 |
| Jun 30, 2021 | -673.00 |
| Mar 31, 2021 | 558.00 |
| Dec 31, 2020 | 2,033.00 |
| Sep 30, 2020 | -766.00 |
| Jun 30, 2020 | -1,182.00 |
| Mar 31, 2020 | -392.00 |
| Dec 31, 2019 | 189.00 |
| Sep 30, 2019 | -189.00 |
| Jun 30, 2019 | 341.00 |
| Mar 31, 2019 | 688.00 |
| Dec 31, 2018 | -417.00 |